Unknown

Dataset Information

0

Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.


ABSTRACT: The last few years have increasingly emphasized the need to develop new active antiviral products obtained from artificial synthesis processes using nanomaterials, but also derived from natural matrices. At the same time, advanced computational approaches have found themselves fundamental in the repurposing of active therapeutics or for reducing the very long developing phases of new drugs discovery, which represents a real limitation, especially in the case of pandemics. The first part of the review is focused on the most innovative nanomaterials promising both in the field of therapeutic agents, as well as measures to control virus spread (i.e., innovative antiviral textiles). The second part of the review aims to show how computer-aided technologies can allow us to identify, in a rapid and therefore constantly updated way, plant-derived molecules (i.e., those included in terpenoids) potentially able to efficiently interact with SARS-CoV-2 cell penetration pathways.

SUBMITTER: Iraci N 

PROVIDER: S-EPMC9405735 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.

Iraci Nunzio N   Corsaro Carmelo C   Giofrè Salvatore V SV   Neri Giulia G   Mezzasalma Angela Maria AM   Vacalebre Martina M   Speciale Antonio A   Saija Antonina A   Cimino Francesco F   Fazio Enza E  

Biomolecules 20220730 8


The last few years have increasingly emphasized the need to develop new active antiviral products obtained from artificial synthesis processes using nanomaterials, but also derived from natural matrices. At the same time, advanced computational approaches have found themselves fundamental in the repurposing of active therapeutics or for reducing the very long developing phases of new drugs discovery, which represents a real limitation, especially in the case of pandemics. The first part of the r  ...[more]

Similar Datasets

| S-EPMC10780089 | biostudies-literature
| S-EPMC5720600 | biostudies-literature
| S-EPMC5114837 | biostudies-literature
| S-EPMC9457765 | biostudies-literature
| S-EPMC7352601 | biostudies-literature
| S-EPMC6689093 | biostudies-literature
| S-EPMC3815155 | biostudies-literature
| S-EPMC9333103 | biostudies-literature
| S-EPMC5789975 | biostudies-literature
| S-EPMC7356584 | biostudies-literature